These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12041368)

  • 61. Laetrile: should the dying patient decide?
    Annas GJ
    Nurs Law Ethics; 1980; 1(7):1+. PubMed ID: 12083144
    [No Abstract]   [Full Text] [Related]  

  • 62. [Simultaneous determination of ephedrine hydrochloride, D-pseudoephedrine and amygdalin in xiao'er pingchuan qutan granule by HPLC].
    Yang DB; Tong Y; Ma ZS; Wang L; Dong MH; Li YL; Wang JY
    Zhongguo Zhong Yao Za Zhi; 2013 Mar; 38(5):687-90. PubMed ID: 23724676
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Government regulation of health-care drugs of questionable efficacy.
    Milis RJ
    San Diego Law Rev; 1977 Mar; 14(2):378-413. PubMed ID: 11663726
    [No Abstract]   [Full Text] [Related]  

  • 64. Laetrile.
    North Dakota
    N D Century Code N D; 1979; Sects. 23.23.1.01 to 23.23.1.03():. PubMed ID: 12043620
    [No Abstract]   [Full Text] [Related]  

  • 65. Laetrile.
    South Dakota
    S D Codif Laws S D; 1979; Sects. 34.14A.1 to 34.14A.8 1979():. PubMed ID: 12043632
    [No Abstract]   [Full Text] [Related]  

  • 66. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
    Kobasic DM
    J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
    [No Abstract]   [Full Text] [Related]  

  • 67. Can a physician sue a pharmaceutical manufacturer when a drug harms a patient?
    Cacciatore GG
    Tex Med; 1997 Mar; 93(3):62-4. PubMed ID: 9062462
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Placebos: a misbranding dilemma.
    Stachowski D
    Health (N Y); 1993; 40(1):102-18. PubMed ID: 11652319
    [No Abstract]   [Full Text] [Related]  

  • 69. When manufacture and sale of laetrile authorized.
    Oregon
    Or Revis Statut Or; 1977; Section 689.885 1977():. PubMed ID: 12041387
    [No Abstract]   [Full Text] [Related]  

  • 70. Consumer's right to know: a new horizon in drug product liability.
    Liccardo SA
    J Prod Liability; 1977; 1(3):165-70. PubMed ID: 11665244
    [No Abstract]   [Full Text] [Related]  

  • 71. Nutritional supplements: laetrile.
    Arizona
    Ariz Revis Statut Annot Ariz; 1978; Sections 36-2451 to 36-2453():. PubMed ID: 12038442
    [No Abstract]   [Full Text] [Related]  

  • 72. Prescribing, administering amygdalin or procaine hydrochloride as grounds for disciplinary action.
    Nevada
    Nev Revis Statut Nev; 1977; Section 633.521 1977():. PubMed ID: 12041369
    [No Abstract]   [Full Text] [Related]  

  • 73. Prescription or administration of amygdalin (laetrile); disciplinary action; signed release by patient.
    Florida
    Wests Fla Statut Annot Fla; 1977; Section 458.24 Effective 1 Oct 1977():. PubMed ID: 12041436
    [No Abstract]   [Full Text] [Related]  

  • 74. Amygdalin (laetrile).
    New Jersey
    N J Statut Annot N J; 1978; Sections 24.6F.1 to 24.6F.5():24:6F-1 to 24:6F-5. PubMed ID: 12043612
    [No Abstract]   [Full Text] [Related]  

  • 75. Use of amygdalin (laetrile).
    Indiana
    Indiana Code Indiana; 1977; Sections 16.8.8.1 to 16.8.8.7 1977():. PubMed ID: 12043672
    [No Abstract]   [Full Text] [Related]  

  • 76. Prescribing, administering amygdalin or procaine hydrochloride as grounds for disciplinary action.
    Nevada
    Nev Revis Statut Nev; 1977; Section 630.303 1977():. PubMed ID: 12041368
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.